A great advantage of this promising GSTP-pro-drug is the fact that, either applied alone or in combination with conventional anti-cancer drugs, it shows no overlapping toxicity, no cross-drug resistance, and even has synergistic effect and last, but not least, it is well tolerated [1,142,152,153]. This evidence concerns the gene GSTP1 and cancer.